Combined Synopsis/Solicitation for Illumina Maintenance Service

The Centers for Disease Control and Prevention (CDC), Genomic Sequencing Laboratory (GSL), Advanced Diagnostics and Biotechnologies Branch (ADBB) intends to award a sole source firm fixed price purchase order to Illumina, Inc. for annual maintenance agreement of NovaSeq and MiSeq instruments. Illumina, Inc. is the manufacturer of these instruments and has been identified as the sole maintenance provider to provide direct/remote repairs, parts and support to ensure the turnaround time required to support outbreak studies and public health emergencies.

This contract action is for supplies or services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b) (SAP) and 10 U.S.C. 2304(c)(1). Interested parties may identify their interest and submit documentation of their capability to respond to the requirement.

This notice of intent is not a request for competitive quotations; however, all responses received by October 21, 2024 will be considered by the government. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the fgovernment. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement.

All responses to this combined synopsis/solicitation must be submitted to James Brown III at xvn8@cdc.gov no later than 12:00 P.M. EDT on Monday, October 21, 2024.